Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15 pseudogene 4 (RPS15P4) is a processed pseudogene derived from the human RPS15 gene, which encodes a structural protein of the 40S ribosomal subunit[2][4]. Unlike the functional RPS15 gene, RPS15P4 does not produce a functional protein and is not a viable molecular target for drug development or research. Such pseudogenes are common in the human genome and typically do not have direct functional or clinical relevance unless shown to play regulatory roles, which has not been demonstrated for RPS15P4. Therefore, it should not be considered a canonical drug target, enzyme, receptor, or transporter in the context of molecular pharmacology or biomedical research[2][4]. RPS15P4 is a pseudogene, not a true therapeutic target, and should not be selected for pharmacological intervention or functional annotation as a protein, receptor, enzyme, or measurable biomarker[2][4].
None (No mechanism as this is not an active molecule; mechanisms relate to the active ribosomal proteins, not pseudogenes[3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15 pseudogene 4 (RPS15P4).